These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22994752)

  • 1. p.R72P, PIN3 Ins16bp polymorphisms of TP53 and CCR5?32 in north Indian breast cancer patients.
    Guleria K; Sharma S; Manjari M; Uppal MS; Singh NR; Sambyal V
    Asian Pac J Cancer Prev; 2012; 13(7):3305-11. PubMed ID: 22994752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 polymorphisms in sporadic North Indian breast cancer patients.
    Sharma S; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR; Bansal D; Gupta A
    Asian Pac J Cancer Prev; 2014; 15(16):6871-9. PubMed ID: 25169539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of TP53 polymorphisms in North Indian sporadic esophageal cancer patients.
    Kaur S; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR; Singh G; Singh H
    Asian Pac J Cancer Prev; 2014; 15(19):8413-22. PubMed ID: 25339039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage disequilibrium and haplotypes of five
    Sambyal V; Kaur S; Manjari M; Uppal MS; Singh NR; Sudan M; Guleria K
    J Genet; 2020; 99():. PubMed ID: 33622989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.
    Marouf C; Tazzite A; Diakité B; Jouhadi H; Benider A; Nadifi S
    Tumour Biol; 2014 Dec; 35(12):12403-8. PubMed ID: 25201062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
    Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
    Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR5Δ32) among breast cancer patients of Pakistan.
    Fatima F; Saleem S; Hameed A; Haider G; Ali Zaidi SA; Kanwal M; Zehra S; Azhar A
    Mol Biol Rep; 2019 Apr; 46(2):2387-2394. PubMed ID: 30848448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley.
    Malik MA; Sharma K; Goel S; Zargar SA; Mittal B
    Oncol Res; 2011; 19(3-4):165-9. PubMed ID: 21473292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.
    Diakite B; Kassogue Y; Dolo G; Kassogue O; Keita ML; Joyce B; Neuschler E; Wang J; Musa J; Traore CB; Kamate B; Dembele E; Nadifi S; Isichei M; Holl JL; Murphy R; Doumbia S; Hou L; Maiga M
    BMC Med Genet; 2020 Jul; 21(1):142. PubMed ID: 32620097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.
    Costa S; Pinto D; Pereira D; Rodrigues H; Cameselle-Teijeiro J; Medeiros R; Schmitt F
    BMC Cancer; 2008 Jan; 8():32. PubMed ID: 18230179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Association between the CCR5Δ32 Polymorphism and Sporadic Esophageal Cancer in Punjab, North-West India.
    Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR; Singh H; Guleria K
    Asian Pac J Cancer Prev; 2015; 16(10):4291-5. PubMed ID: 26028088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TP53 gene polymorphisms and survival of sporadic breast cancer patients.
    Bišof V; Salihović MP; Narančić NS; Skarić-Jurić T; Jakić-Razumović J; Janićijević B; Rudan P
    Med Oncol; 2012 Jun; 29(2):472-8. PubMed ID: 21365326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
    Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
    Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects.
    Sagne C; Marcel V; Amadou A; Hainaut P; Olivier M; Hall J
    Cell Death Dis; 2013 Feb; 4(2):e492. PubMed ID: 23412385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 and p53 codon 72 gene polymorphisms: implications in breast cancer development.
    Aoki MN; da Silva do Amaral Herrera AC; Amarante MK; do Val Carneiro JL; Fungaro MH; Watanabe MA
    Int J Mol Med; 2009 Mar; 23(3):429-35. PubMed ID: 19212663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.
    Schmidt MK; Tommiska J; Broeks A; van Leeuwen FE; Van't Veer LJ; Pharoah PD; Easton DF; Shah M; Humphreys M; Dörk T; Reincke SA; Fagerholm R; Blomqvist C; Nevanlinna H
    Breast Cancer Res; 2009; 11(6):R89. PubMed ID: 20021639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
    Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
    J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis.
    Cheng H; Ma B; Jiang R; Wang W; Guo H; Shen N; Li D; Zhao Q; Wang R; Yi P; Zhao Y; Liu Z; Huang T
    Mol Biol Rep; 2012 Sep; 39(9):9265-74. PubMed ID: 22729912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
    van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
    Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
    Tommiska J; Eerola H; Heinonen M; Salonen L; Kaare M; Tallila J; Ristimäki A; von Smitten K; Aittomäki K; Heikkilä P; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2005 Jul; 11(14):5098-103. PubMed ID: 16033823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.